Global Radiotheranostics Market Report 2024

Radiotheranostics Global Market Report 2025 – By Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes ), By Approach (Targeted Therapeutic, Targeted Diagnostic), By Application (Oncology, Non-Oncology), By End-Users (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Radiotheranostics Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Radiotheranostics Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Radiotheranostics Market Definition

Radiotheranostics refers to diagnoses and treatments that utilize imaging methods with radioactive substances to pinpoint specific targets in the body. It is used to administer targeted radiation therapy to defined locations, allowing for precise and tailored cancer treatment while minimizing harm to healthy tissues to enhance treatment results and patient care.

The main radio theranostics radioisotopes are technetium-99, gallium-68, iodine-131, iodine-123, fludeoxyglucose-18F, yttrium-90, lutetium (Lu) 177, copper (Cu) 67, copper (Cu) 64, and others. Technetium (Tc) is a silver-gray radioactive metal that exists naturally at extremely minute levels in the earth's crust but is mostly man-made and is used to scan the skeleton and heart muscle, but it is also utilized to picture the brain, thyroid, and lungs, liver, spleen, kidney, gall bladder, bone marrow, salivary and lachrymal glands, and some specialized medical research. The various approaches are targeted therapeutic and targeted diagnostic that is applied in oncology and non-oncology. The end users are hospitals and clinics, pharmaceutical and biotechnology companies, and others.

Radiotheranostics Market Segmentation

The radiotheranostics market covered in this report is segmented –

1) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes

2) By Approach: Targeted Therapeutic, Targeted Diagnostic

3) By Application: Oncology, Non-Oncology

4) By End-Users: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Technetium-99: Technetium-99m, Technetium-99 Pertechnetate

2) By Gallium-68: Gallium-68 DOTATATE, Gallium-68 PSMA

3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment, Iodine-131 For Hyperthyroidism Treatment

4) By Iodine-123: Iodine-123 For Thyroid Scans, Iodine-123 For Cardiac Imaging

5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging, FDG For Brain Imaging

6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer, Yttrium-90 For Radioimmunotherapy

7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer, Lutetium-177 DOTATATE For Neuroendocrine Tumors

8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy, Copper-67 In Clinical Trials

9) By Copper (Cu) 64: Copper-64 For PET Imaging, Copper-64 For Radiotherapy

10) By Other Radioisotopes: Radium-223, Samarium-153, Other Emerging Radioisotopes In Theranostics

Radiotheranostics Market Size and growth rate 2025 to 2029: Graph

Radiotheranostics Market Size 2025 And Growth Rate

The radiotheranostics market size has grown rapidly in recent years. It will grow from $8.79 billion in 2024 to $10.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to advancements in nuclear medicine, a rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards

Radiotheranostics Market Growth Forecast

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $16.94 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, and growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization.

Radiotheranostics Market Driver: Rising Prevalence Of Cancer To Drive Market Growth

The increasing prevalence of cancer is expected to propel the growth of the radiotheranostics market going forward. Cancer is a condition in which some cells in the body develop uncontrollably and spread to other regions of the body. Radiotheranostics medicines are commonly employed in cancer to offer the ultimate notion of customized medicine by using paired diagnostic and therapeutic radionuclide probes for the selective and targeted detection and treatment of specific (typically cancer) cells, each of which is suited to the patient's underlying condition to enhance treatment efficiency and better clinical output. For instance, in January 2024, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, the number of cancer cases increased to 2,001,140 compared to 1,958,310 in 2023, reflecting a growth of 2.19%. Therefore, the increasing prevalence of cancer drives the radiotheranostics market.

Radiotheranostics Market Driver: Rising Adoption Of Personalized Medicine To Drive Market Growth

The increasing adoption of personalized medicine is expected to propel the growth of radiotheranostics market going forward. Personalized medicine is an innovative healthcare approach that tailors medical treatment and interventions to the individual characteristics of each patient. Using specific radiopharmaceuticals, radiotheranostics enables the identification of individualized molecular targets, allowing for precise diagnosis and tailored therapeutic interventions based on a patient's unique characteristics. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the increasing adoption of personalized medicine is driving the growth of radiotheranostics market.

Global Radiotheranostics Market Major Players

Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

Global Radiotheranostics Market Trend: Product Innovations Transforming The Radiotheranostics Market

Product innovations are a key trend gaining popularity in the radiotheranostics market. Significant companies are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Advanced Cyclotron Systems Inc., a Canada-based company that supplies and services cyclotrons predominantly used for producing medical isotopes, introduced TR-ALPHA for producing alpha-emitting radioisotopes to treat cancer. It is an appropriate solution to the market demand for a low-cost cyclotron capable of producing vast amounts of Astatine-211, one of the most promising alpha-emitting radioisotopes. The TR-ALPHA is also far smaller, less costly, and simpler to run than previous cyclotron models capable of manufacturing alpha-emitting radioisotopes. It is the ideal solution for hospitals, researchers, and institutions interested in running a dedicated cyclotron to efficiently produce enormous amounts of therapeutic alpha-emitting radioisotopes.

Global Radiotheranostics Market Trend: Strategic Partnerships Reshaping The Radiotheranostics Market

Major companies operating in the radiotheranostics market are forming partnerships to develop new products and strengthen their positions in the market. Collaborations and partnerships in the radiotheranostics market facilitate the pooling of resources, expertise, and research efforts among institutions, pharmaceutical companies, and healthcare providers, accelerating the development, commercialization, and widespread adoption of advanced diagnostic and therapeutic solutions. For instance, in April 2022, Ion Beam Applications, a Belgium-based medical technology company, partnered with SCK CEN, a Belgium-based research center to advance the production of the radioisotope Actinium-225, a promising element in cancer treatment. Through the partnership, they aim to establish a state-of-the-art production facility in Mol, Belgium, combining IBA's expertise in particle accelerators with SCK CEN's proficiency in providing rare raw materials. This collaboration is anticipated to enable large-scale production of Actinium-225, a crucial step in making radiotheranostic solutions commercially viable for treating a variety of cancers with enhanced precision.

Radiotheranostics Market Merger And Acquisition: Ariceum Therapeutics Strengthens Radiopharmaceutical Portfolio With Acquisition Of Theragnostics Ltd

In June 2023, Ariceum Therapeutics GmbH, a Germany-based radiopharmaceutical company, acquired Theragnostics Ltd. for $41.5 million. With the acquisition, Ariceum aims to broaden its portfolio of therapeutic and diagnostic assets in late preclinical and early clinical development and to extend its operations in the US. Theranostics Ltd. is a US-based radiopharmaceutical company that offers radio-theranostics.

Regional Outlook For The Global Radiotheranostics Market

North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the radiotheranostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Radiotheranostics Market?

The radiotheranostics market consists of sales of iodine-125, radium-223 (223Ra), astatin-211 (211At), actinium-225 (225Ac), lead-212 (212Pb), bismuth-212 (212Bi), thorium-227, strontium-89 (89Sr), rhenium-188 (188Re), and samarium-153 (153Sm). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Radiotheranostics Industry?

The radio theranostics market research report is one of a series of new reports from The Business Research Company that provides radio theranostics market statistics, including radio theranostics industry global market size, regional shares, competitors with a radio theranostics market share, detailed radio theranostics market segments, market trends, and opportunities, and any further data you may need to thrive in the radio theranostics industry. This radio theranostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Radiotheranostics Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $10.07 billion
Revenue Forecast In 2034 $16.94 billion
Growth Rate CAGR of 13.9% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes
2) By Approach: Targeted Therapeutic, Targeted Diagnostic
3) By Application: Oncology, Non-Oncology
4) By End-Users: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Technetium-99: Technetium-99m, Technetium-99 Pertechnetate
2) By Gallium-68: Gallium-68 DOTATATE, Gallium-68 PSMA
3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment, Iodine-131 For Hyperthyroidism Treatment
4) By Iodine-123: Iodine-123 For Thyroid Scans, Iodine-123 For Cardiac Imaging
5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging, FDG For Brain Imaging 6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer, Yttrium-90 For Radioimmunotherapy 7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer, Lutetium-177 DOTATATE For Neuroendocrine Tumors 8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy, Copper-67 In Clinical Trials 9) By Copper (Cu) 64: Copper-64 For PET Imaging, Copper-64 For Radiotherapy 10) By Other Radioisotopes: Radium-223, Samarium-153, Other Emerging Radioisotopes In Theranostics
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Radiotheranostics Market Characteristics

    3. Radiotheranostics Market Trends And Strategies

    4. Radiotheranostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Radiotheranostics Growth Analysis And Strategic Analysis Framework

    5.1. Global Radiotheranostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Radiotheranostics Market Growth Rate Analysis

    5.4. Global Radiotheranostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Radiotheranostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Radiotheranostics Total Addressable Market (TAM)

    6. Radiotheranostics Market Segmentation

    6.1. Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Technetium-99

    Gallium-68

    Iodine-131

    Iodine-123

    Fludeoxyglucose-18F

    Yttrium-90

    Lutetium (Lu) 177

    Copper (Cu) 67

    Copper (Cu) 64

    Other Radioisotopes

    6.2. Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Targeted Therapeutic

    Targeted Diagnostic

    6.3. Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Oncology

    Non-Oncology

    6.4. Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals And Clinics

    Pharmaceutical And Biotechnology Companies

    Other End-Users

    6.5. Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Technetium-99m

    Technetium-99 Pertechnetate

    6.6. Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Gallium-68 DOTATATE

    Gallium-68 PSMA

    6.7. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Iodine-131 For Thyroid Cancer Treatment

    Iodine-131 For Hyperthyroidism Treatment

    6.8. Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Iodine-123 For Thyroid Scans

    Iodine-123 For Cardiac Imaging

    6.9. Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    FDG For Oncology Imaging

    FDG For Brain Imaging

    6.10. Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Yttrium-90 Microspheres For Liver Cancer

    Yttrium-90 For Radioimmunotherapy

    6.11. Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Lutetium-177 PSMA For Prostate Cancer

    Lutetium-177 DOTATATE For Neuroendocrine Tumors

    6.12. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Copper-67 For Targeted Radiotherapy

    Copper-67 In Clinical Trials

    6.13. Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Copper-64 For PET Imaging

    Copper-64 For Radiotherapy

    6.14. Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Radium-223; Samarium-153

    Other Emerging Radioisotopes In Theranostics

    7. Radiotheranostics Market Regional And Country Analysis

    7.1. Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Radiotheranostics Market

    8.1. Asia-Pacific Radiotheranostics Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Radiotheranostics Market

    9.1. China Radiotheranostics Market Overview

    9.2. China Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Radiotheranostics Market

    10.1. India Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Radiotheranostics Market

    11.1. Japan Radiotheranostics Market Overview

    11.2. Japan Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Radiotheranostics Market

    12.1. Australia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Radiotheranostics Market

    13.1. Indonesia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Radiotheranostics Market

    14.1. South Korea Radiotheranostics Market Overview

    14.2. South Korea Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Radiotheranostics Market

    15.1. Western Europe Radiotheranostics Market Overview

    15.2. Western Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Radiotheranostics Market

    16.1. UK Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Radiotheranostics Market

    17.1. Germany Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Radiotheranostics Market

    18.1. France Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Radiotheranostics Market

    19.1. Italy Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Radiotheranostics Market

    20.1. Spain Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Radiotheranostics Market

    21.1. Eastern Europe Radiotheranostics Market Overview

    21.2. Eastern Europe Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Radiotheranostics Market

    22.1. Russia Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Radiotheranostics Market

    23.1. North America Radiotheranostics Market Overview

    23.2. North America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Radiotheranostics Market

    24.1. USA Radiotheranostics Market Overview

    24.2. USA Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Radiotheranostics Market

    25.1. Canada Radiotheranostics Market Overview

    25.2. Canada Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Radiotheranostics Market

    26.1. South America Radiotheranostics Market Overview

    26.2. South America Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Radiotheranostics Market

    27.1. Brazil Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Radiotheranostics Market

    28.1. Middle East Radiotheranostics Market Overview

    28.2. Middle East Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Radiotheranostics Market

    29.1. Africa Radiotheranostics Market Overview

    29.2. Africa Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Radiotheranostics Market Competitive Landscape And Company Profiles

    30.1. Radiotheranostics Market Competitive Landscape

    30.2. Radiotheranostics Market Company Profiles

    30.2.1. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. GE Healthcare Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    31. Radiotheranostics Market Other Major And Innovative Companies

    31.1. Siemens Healthineers

    31.2. Orano Med

    31.3. Curium SAS

    31.4. IBA Molecular

    31.5. The Eckert & Ziegler Group

    31.6. Advanced Accelerator Applications (AAA)

    31.7. Telix Pharmaceuticals Limited.

    31.8. Abdera Therapeutics

    31.9. Blue Earth Diagnostics

    31.10. Sirtex Medical Limited

    31.11. Y-mAbs Therapeutics Inc.

    31.12. ITM Radiopharma

    31.13. NorthStar Medical Radioisotopes LLC

    31.14. Trasis S.A.

    31.15. Molecular Targeting Technologies Inc.

    32. Global Radiotheranostics Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Radiotheranostics Market

    34. Recent Developments In The Radiotheranostics Market

    35. Radiotheranostics Market High Potential Countries, Segments and Strategies

    35.1 Radiotheranostics Market In 2029 - Countries Offering Most New Opportunities

    35.2 Radiotheranostics Market In 2029 - Segments Offering Most New Opportunities

    35.3 Radiotheranostics Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Asia-Pacific, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Asia-Pacific, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Asia-Pacific, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: China, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: China, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: China, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: India, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: India, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: India, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Japan, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Japan, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Japan, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Australia, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Australia, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Australia, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Indonesia, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Indonesia, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Indonesia, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: South Korea, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: South Korea, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: South Korea, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Western Europe, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Western Europe, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Western Europe, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: UK, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: UK, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: UK, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Germany, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Germany, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Germany, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: France, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: France, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: France, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Italy, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Italy, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Italy, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Spain, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Spain, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Spain, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Eastern Europe, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Eastern Europe, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Eastern Europe, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Russia, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Russia, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Russia, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: North America, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: North America, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: North America, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: USA, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: USA, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: USA, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Canada, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Canada, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Canada, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: South America, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: South America, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: South America, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Brazil, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Brazil, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Brazil, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Middle East, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Middle East, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Middle East, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Africa, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 83: Africa, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 84: Africa, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 85: Lantheus Holdings Inc. Financial Performance
  • Table 86: Cardinal Health Inc. Financial Performance
  • Table 87: GE Healthcare Inc. Financial Performance
  • Table 88: Bayer AG Financial Performance
  • Table 89: Novartis AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Radiotheranostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Radiotheranostics Market, Sub-Segmentation Of Technetium-99, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Radiotheranostics Market, Sub-Segmentation Of Gallium-68, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Radiotheranostics Market, Sub-Segmentation Of Iodine-131, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Radiotheranostics Market, Sub-Segmentation Of Iodine-123, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Radiotheranostics Market, Sub-Segmentation Of Fludeoxyglucose-18F (FDG), By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Radiotheranostics Market, Sub-Segmentation Of Yttrium-90, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Radiotheranostics Market, Sub-Segmentation Of Lutetium (Lu) 177, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 67, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Radiotheranostics Market, Sub-Segmentation Of Copper (Cu) 64, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Global Radiotheranostics Market, Sub-Segmentation Of Other Radioisotopes, By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Global Radiotheranostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Global Radiotheranostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Asia-Pacific, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Asia-Pacific, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Asia-Pacific, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: China, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: China, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: China, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: India, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: India, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: India, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Japan, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Japan, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Japan, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Australia, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Australia, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Australia, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Indonesia, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Indonesia, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Indonesia, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: South Korea, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: South Korea, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: South Korea, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Western Europe, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Western Europe, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Western Europe, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: UK, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: UK, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: UK, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Germany, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Germany, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Germany, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: France, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: France, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: France, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Italy, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Italy, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Italy, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Spain, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Spain, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Spain, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Eastern Europe, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Eastern Europe, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Eastern Europe, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Russia, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Russia, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Russia, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: North America, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: North America, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: North America, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: USA, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: USA, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: USA, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Canada, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Canada, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Canada, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: South America, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: South America, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: South America, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Brazil, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Brazil, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Brazil, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Middle East, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Middle East, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Middle East, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Africa, Radiotheranostics Market, Segmentation By Radioisotope, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 83: Africa, Radiotheranostics Market, Segmentation By Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 84: Africa, Radiotheranostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 85: Lantheus Holdings Inc. Financial Performance
  • Figure 86: Cardinal Health Inc. Financial Performance
  • Figure 87: GE Healthcare Inc. Financial Performance
  • Figure 88: Bayer AG Financial Performance
  • Figure 89: Novartis AG Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Radiotheranostics market?

Radiotheranostics refers to diagnoses and treatments that utilize imaging methods with radioactive substances to pinpoint specific targets in the body. It is used to administer targeted radiation therapy to defined locations, allowing for precise and tailored cancer treatment while minimizing harm to healthy tissues to enhance treatment results and patient care. For further insights on the Radiotheranostics market, request a sample here

How will the Radiotheranostics market drivers and restraints affect the market dynamics? What forces will shape the Radiotheranostics industry going forward?

The Radiotheranostics market major growth driver - Rising Prevalence Of Cancer To Drive Market Growth. For further insights on the Radiotheranostics market, request a sample here

What is the forecast market size or the forecast market value of the Radiotheranostics market?

The Radiotheranostics market size has grown strongly in recent years. The radiotheranostics market size has grown rapidly in recent years. It will grow from $8.79 billion in 2024 to $10.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to advancements in nuclear medicine, a rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $16.94 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, and growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization. For further insights on the Radiotheranostics market, request a sample here

How is the Radiotheranostics market segmented?

The radiotheranostics market covered in this report is segmented –
1) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes
2) By Approach: Targeted Therapeutic, Targeted Diagnostic
3) By Application: Oncology, Non-Oncology
4) By End-Users: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments:
1) By Technetium-99: Technetium-99m, Technetium-99 Pertechnetate
2) By Gallium-68: Gallium-68 DOTATATE, Gallium-68 PSMA
3) By Iodine-131: Iodine-131 For Thyroid Cancer Treatment, Iodine-131 For Hyperthyroidism Treatment
4) By Iodine-123: Iodine-123 For Thyroid Scans, Iodine-123 For Cardiac Imaging
5) By Fludeoxyglucose-18F (FDG): FDG For Oncology Imaging, FDG For Brain Imaging
6) By Yttrium-90: Yttrium-90 Microspheres For Liver Cancer, Yttrium-90 For Radioimmunotherapy
7) By Lutetium (Lu) 177: Lutetium-177 PSMA For Prostate Cancer, Lutetium-177 DOTATATE For Neuroendocrine Tumors
8) By Copper (Cu) 67: Copper-67 For Targeted Radiotherapy, Copper-67 In Clinical Trials
9) By Copper (Cu) 64: Copper-64 For PET Imaging, Copper-64 For Radiotherapy
10) By Other Radioisotopes: Radium-223, Samarium-153, Other Emerging Radioisotopes In Theranostics For further insights on the Radiotheranostics market,
request a sample here

Which region has the largest share of the Radiotheranostics market? What are the other regions covered in the report?

North America was the largest region in the radiotheranostics market in 2024. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Radiotheranostics market, request a sample here.

Who are the major players in the Radiotheranostics market?

Major companies operating in the radiotheranostics market include Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc. . For further insights on the Radiotheranostics market, request a sample here.

What are the key trends in the Radiotheranostics market?

Major trends in the Radiotheranostics market include Product Innovations Transforming The Radiotheranostics Market. For further insights on the Radiotheranostics market, request a sample here.

What are the major opportunities in the Radiotheranostics market? What are the strategies for the Radiotheranostics market?

For detailed insights on the major opportunities and strategies in the Radiotheranostics market, request a sample here.

How does the Radiotheranostics market relate to the overall economy and other similar markets?

For detailed insights on Radiotheranostics's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Radiotheranostics industry?

For detailed insights on the mergers and acquisitions in the Radiotheranostics industry, request a sample here.

What are the key dynamics influencing the Radiotheranostics market growth? SWOT analysis of the Radiotheranostics market.

For detailed insights on the key dynamics influencing the Radiotheranostics market growth and SWOT analysis of the Radiotheranostics industry, request a sample here.